Skip to main content
. Author manuscript; available in PMC: 2021 Nov 15.
Published in final edited form as: Cancer. 2020 Sep 21;126(22):4957–4966. doi: 10.1002/cncr.33121

Table 3.

Frequency of delayed treatment initiation and prolonged treatment duration by race, and latent classes of SES and access to care in Carolina Breast Cancer Study 3 (2008-2013)a

Treatment initiation Treatment durationb


White
Black
White
Black
≤60 days >60 days ≤60 days >60 days Q1-Q3 Q4 Q1-Q3 Q4
No. (%) No. (%) No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
SES latent classes
   High SES 927 (93.3) 67 (6.7) 451 (88.3) 60 (11.7) 808 (81.3) 186 (18.7) 384 (75.1) 127 (24.9)
   Low SES 406 (89.4) 48 (10.6) 755 (85.6) 127 (14.4) 335 (73.8) 119 (26.2) 592 (67.1) 290 (32.9)
   Low vs. high, RFD (95% CI) ref 3.5% (1.1, 5.9) ref 2.4% (−1.3, 6.0) ref 8.1% (4.7, 11.5) ref 8.4% (3.5, 13.3)
Access to care latent classesc
   Fewer Barriers to Care 1259 (92.2) 107 (7.8) 1052 (87.0) 157 (13.0) 1084 (79.4) 263 (20.6) 870 (72.0) 339 (28.0)
   More Barriers to Care 74 (90.2) 8 (9.8) 153 (83.6) 30 (16.4) 59 (71.9) 28 (28.1) 105 (57.4) 78 (42.6)
   More vs. fewer, RFD (95% CI) ref 2.8% (−1.6, 7.2) ref 3.6% (−2.1, 9.3) ref 11.7% (5.5, 17.8) ref 14.1% (6.5, 21.8)
a

Multivariate models adjusting for age

b

Quartiles were separately defined by modality and Q4 was equal to 56, 74, 119 days for radiation, definitive surgery, and chemotherapy modalities, respectively

c

n=2840

Abbreviations: CI, confidence interval; RFD, relative frequency difference; SES, socioeconomic status